Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
ST
Stevanato Group S.p.A.
STVN
Mkt Cap
$5.17B
Volume
228.75K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
ST
STVN
ST
Stevanato Group S.p.A.
STVN
News
·
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
Mkt Cap
$5.26B
Volume
228.75K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
United Therapeutics shares surged 12.5% following a Delaware court ruling that Liquidia's Yutrepia infringes on UTHR's patent for inhaled treprostinil, potentially restricting competition for UTHR's Tyvaso products. However, the stock faces headwinds as consensus EPS estimates were revised 1.4% lower over the past 30 days, and the company is expected to report declining earnings and flat revenue growth.
Zacks Investment Research · Oct 1, 2026
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?
electroCore (ECOR) shares surged 6.9% to $11.38 following raised 2026 revenue-growth outlook of over 30% and improved operating performance. Q2 revenues increased 28% YoY to $9.5 million with narrowed adjusted EBITDA losses. However, the stock carries a Zacks Rank #3 (Hold) as earnings estimate revisions have remained flat over the past 30 days.
Zacks Investment Research · Sep 18, 2026
Pharmaceutical Glass Packaging Market Forecast: Growth from USD 5.32 Billion in 2025 to USD 12.39 Billion by 2035
The global pharmaceutical glass packaging market is projected to grow from USD 5.32 billion in 2025 to USD 12.39 billion by 2035, with a CAGR of 8.82%. Growth is driven by rising demand for injectables, biologics, and GLP-1 therapies, alongside stringent EU regulatory requirements for sustainability and anti-counterfeiting measures. Europe, particularly Germany, is expected to be a major growth contributor.
GlobeNewswire Inc. · Feb 24, 2026
Europe Glass Prefilled Syringes and Glass Vials Packaging Equipment Market Trends 2035
The European market for glass prefilled syringes and glass vials packaging equipment is projected to grow from USD 283.30 billion in 2025 to USD 389.13 billion by 2034, driven by rising demand for injectable biologics, sterile drug delivery systems, and advanced healthcare infrastructure.
GlobeNewswire Inc. · Dec 1, 2025
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight
The global prefilled syringes market is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection. The market is expected to reach USD 28 billion by 2032, with North America leading the growth.
GlobeNewswire Inc. · Apr 10, 2025
Dual Chamber Prefilled Syringes Market Size is Projected to Reach US$ 5,495.5 Million by 2034 | Fact.MR
The global dual chamber prefilled syringes market is expected to grow at a CAGR of 9.0% from 2024 to 2034, driven by the increased demand for biologics and biosimilars. The market is projected to reach a valuation of US$ 5,495.5 million by 2034.
GlobeNewswire Inc. · Sep 18, 2024
USNA vs. STVN: Which Stock Should Value Investors Buy Now?
USNA vs. STVN: Which Stock Is the Better Value Option?
Zacks Investment Research · May 20, 2024
USNA or STVN: Which Is the Better Value Stock Right Now?
USNA vs. STVN: Which Stock Is the Better Value Option?
Zacks Investment Research · May 2, 2024
Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Fusion Pharmaceuticals (FUSN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research · May 2, 2024
Stevanato Group (STVN) to Report Q1 Results: What You Should Expect
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research · Apr 25, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
ST
STVN
Stevanato Group S.p.A.
Buy
Sell
Market
Limit
Soon
STVN
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any STVN yet.
Related Tickers
Earnings
Dividends
Last · Jun 11
Annual
Amount
$0.0620
Yield
0.33%
Annual
$0.0620